Oramed Pharmaceuticals Stock Forecast

Hold candidate since Nov 17, 2025

The Oramed Pharmaceuticals Inc. stock price gained 0.429% on the last trading day (Monday, 17th Nov 2025), rising from $2.33 to $2.34. During the last trading day the stock fluctuated 3.98% from a day low at $2.26 to a day high of $2.35. The price has fallen in 6 of the last 10 days and is down by -0.85% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 611 thousand more shares were traded than the day before. In total, 685 thousand shares were bought and sold for approximately $1.60 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.81% during the next 3 months and, with a 90% probability hold a price between $2.36 and $2.99 at the end of this 3-month period.

ORMP Signals & Forecast

There are mixed signals in the stock today. The Oramed Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.35 and $2.37. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 6.85%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Oramed Pharmaceuticals Inc. stock

Oramed Pharmaceuticals Inc. finds support from accumulated volume at $2.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0900 between high and low, or 3.98%. For the last week, the stock has had daily average volatility of 5.07%.

Our recommended stop-loss: $2.24 (-4.10%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (ORMP) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Oramed Pharmaceuticals Inc. to open at $2.32, and during the day (based on 14 day Average True Range), to move between $2.28 and $2.40, which gives a possible trading interval of +/-$0.113 (+/-4.93%) up or down from last closing price. If Oramed Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 4.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.37 (1.28%) than the support at $2.28 (2.56%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Oramed Pharmaceuticals Inc. stock A Buy?

Oramed Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.700 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.32 ( 1.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk